PatientRightsAdvocate.org Launches Nationwide Hospital Drug Price Finder
Empowering Americans to compare prices, save on care, fight overcharges
The report found across hospitals that the average maximum-to-minimum negotiated price ratio is 2,347x. Meaning, one insurer might pay
"PatientRightsAdvocate.org applauds 3 Axis Advisors for bringing to light the wide price variation and egregious lack of useable pricing data on prescription drugs in hospitals nationwide," said PRA Founder and Chairman
"We are proud to release a brand new tool to equip Americans with easily searchable drug prices in hospitals across the country," Fisher continued. "Shifting the power to the consumer empowers Americans to live longer and healthier lives at a much lower cost."
The new tool will allow consumers to compare drug prices across all health plans and the cash price, across regions and hospitals, to be equipped with upfront prices to compare or provide remedy for overcharges without having to navigate complex pricing files.
"We have known for years that the list prices of drugs charged by manufacturers are well inflated relative to their actual cost. But to see health insurers paying hospitals more than four times those list prices is enough to redefine what it means to be inflated in the first place," said
Access the tool by PatientRightsAdvocate.org here. Read the new report from 3 Axis Advisors here.
PatientRightsAdvocate.org (PRA) is a leading national healthcare price transparency organization dedicated to ushering in systemwide transparency through advocacy, testimony, media, legal research, and grassroots campaigns. PRA believes that the availability and visibility of actual, upfront healthcare prices will greatly lower costs for patients and employers through a functional, competitive healthcare marketplace.
View original content to download multimedia:https://www.prnewswire.com/news-releases/patientrightsadvocateorg-launches-nationwide-hospital-drug-price-finder-302705265.html
SOURCE Patient Rights Advocate
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Akiram Therapeutics and ITM Sign Lutetium-177 Supply Agreement to Support Development of AKIR001 for the Treatment of Solid Tumors
- Michelin: Disclosure of trading in own shares - 20 AUGU 2026
- Open-Source Enterprise AI Platform FastGPT Releases v4.16.0 with User-Level Code Sandboxes and Knowledge Base Metadata
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share